Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport.

scientific article

Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2967/JNUMED.107.047886
P698PubMed publication ID18632807
P5875ResearchGate publication ID51407388

P50authorTim A D SmithQ40098754
P2093author name stringRituka I Sharma
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectirinotecanQ412197
cetuximabQ420296
oxaliplatinQ422327
glycobiologyQ899224
colonic neoplasmQ3542029
P304page(s)1386-1394
P577publication date2008-07-16
P1433published inThe Journal of Nuclear MedicineQ7743608
P1476titleColorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport
P478volume49